Today, more than 131 million Americans – 66 percent of all adults in the U.S. – use prescription drugs, and one in four use three or more, according to the Health Policy Institute. Not only are we being prescribed more drugs than ever before, but we’re paying more for them too: the U.S. has the highest per-capita pharmaceutical spending among the developed countries. In 2021, the U.S. healthcare system spent $603 billion on prescription drugs.
But even as we’re being prescribed more drugs,
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Half of Doctors/Nurses Eager to Adopt Generative AI Tools
What You Should Know:
Elsevier Health, a global leader in information and data analytics, released its Clinician of the Future 2023 report, which serves as the global health ecosystem’s most recent pulse on what doctors and nurses think about the changes and challenges in healthcare, including the rapid rise of generative AI products and platforms.The report finds that almost half of all doctors and nurses are eager for physicians to utilize this innovative technology in the future to
Read More
Researchers Develop DNA Biosensor for Early Cervical Cancer Diagnosis
What You Should Know:
Recently, researchers from Chung-Ang University developed an electrochemical DNA biosensor with enhanced sensitivity for effective HPV detection with high specificity.They achieved this feat using a graphitic nano-onion/molybdenum disulfide nanosheet composite with improved conductive electron transfer compared to the nanosheet alone. Their breakthrough can open doors to the development of electrochemical biosensors for early diagnosis of various ailments.
Effective
Read More
Ibex Launches Breast Cancer Biomarker Diagnostic Platform
What You Should Know:
Ibex Medical Analytics launches Galen Breast HER2™, a novel breast cancer AI-powered biomarker scoring solution developed in collaboration with AstraZeneca and Daiichi Sankyo, to support improved patient outcomes.Galen Breast HER2 is an AI-powered biomarker scoring solution to aid pathologists with reproductible HER2 assessment for breast cancer. The platform allows clinicians to rapidly and accurately identify patients with HER2-low who would benefit from
Read More
Philips Reaches US Economic Loss Resolution for Respiratory Device Recall
What You Should Know:
- Philips Respironics, has reached an agreement to resolve all economic loss claims in the US Multidistrict Litigation (MDL) related to Philips Respironics’ voluntary recall of certain sleep and respiratory care devices.
- The agreement will provide predefined cash awards to all eligible participants in the US depending on the type of device, extended warranties on all replacement devices, and an additional cash award if they return the recalled device
Read More
OM1 Launches Parkinson’s Disease Real-World Datasets for Neuroscience
What You Should Know:
Today, OM1 announced the launch of its Parkinson’s Disease datasets, enhancing its Mental Health & Neuroscience Real-World Data Network.OM1’s Mental Health & Neuroscience Real-World Data Network, which already includes robust datasets focused on Major Depressive Disorder, Multiple Sclerosis, Bipolar Disorder I and Schizophrenia, will further expand to include Alzheimer’s Disease in the coming months.
Parkinson’s Disease Premium Dataset
Nearly
Read More
GE Healthcare, Mass General Brigham Co-Develop AI Algorithm for Radiology Scheduling Predictions
What You Should Know:
- GE HealthCare and Mass General Brigham form a strategic collaboration on the co-development of an artificial intelligence (AI) algorithm that will help increase scheduling operations effectiveness and productivity.
- The first innovative AI app from the collaboration is the schedule predictions dashboard of Radiology Operations Module (ROM), a digital imaging tool that helps optimize scheduling, reduce cost, and free providers from administrative burden, allowing
Read More
FDA Taps Flatiron for 5-Year Real-World Data Collaboration
What You Should Know:
Flatiron Health today announced its renewed collaboration with the Oncology Center of Excellence (OCE) of FDA to jointly develop and implement specific research projects to advance the use of Real World Data (RWD) and explore the potential strengths and limitations of using Real World Evidence (RWE) for regulatory purposes.The partnership will specifically evaluate RWD study designs and analytic methods through the collaborative development of priority, clinically
Read More
Ibex Medical Analytics Raises $55M to Drive AI for Cancer Diagnosis Adoption Globally
What You Should Know:
– Ibex Medical Analytics (Ibex), a provider of AI-powered cancer diagnostics raises $55M in Series C financing round led by 83North.
- The round also included participation from Sienna Venture Capital and existing investors in the company, Octopus Ventures, aMoon, Planven Entrepreneur Ventures and Dell Technologies Capital. The financing brings total funding to over $100M since Ibex’s inception in 2016.
Read More
Augmedix Expands AI Medical Documentation to Behavioral Health Market
What You Should Know:
- Augmedix announced today the expansion of the company’s ambient medical documentation products to the behavioral healthcare market.
Augmedix currently supports behavioral healthcare entities with its Augmedix Live and Augmedix Notes products and will supplement those with its newest product, Augmedix Go, later this year.
Reduces Burnout for Behavioral Health Clinicians
Nearly half of psychologists report burnout or the inability to meet patient demand.
Read More
